ANTITRUST POLICY related term(s) Monopolies

Amendments

Dept. of the Treasury: disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), consideration (H. Res. 426), H2166 [20MY]

Bills and resolutions

Business and industry: reform laws to protect competition, modify standard for unlawful acquisitions, deter anticompetitive exclusionary practices, and enhance ability of Federal agencies to enforce such laws (see S. 130), S226 [16JA]

Courts: eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (see S. 2799), S6599 [15SE] (see H.R. 5350), H4309 [15SE]

Dept. of Agriculture: establish Office of the Special Investigator for Competition Matters (see S. 1312), S2456 [7AP] (see H.R. 1380), H714 [14FE]

Dept. of HHS: direct Assistant Sec. for Planning and Evaluation to conduct annual study on health care competition and consolidation at State level (see H.R. 3017), H1623 [24AP]

Dept. of Justice: prevent conflicts of interest and promote competition in sale and purchase of digital advertising (see S. 1060), S1743 [13MR]

Dept. of the Treasury: disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (see S.J. Res. 13), S594 [4FE] (see H.J. Res. 92), H1600 [10AP]

——— disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), consideration (see H. Res. 426), H2145 [19MY]

FTC: prohibit anticompetitive use of patents, known as product hopping, by drug product manufacturers (see S. 1040), S1742 [13MR]

——— prohibit use of pricing algorithms that can facilitate collusion through use of nonpublic competitor data and create antitrust law enforcement audit tool (see S. 232), S335 [23JA]

——— transfer antitrust enforcement to Dept. of Justice (see S. 1059), S1743 [13MR] (see H.R. 384), H148 [14JA]

GAO: evaluate effects of anticompetitive contracting clauses in contracts between health insurers and health care providers and assess FTC and Dept. of Justice antitrust enforcement actions relative to such clauses (see H.R. 3020), H1624 [24AP]

——— study commitments and conditions relative to insured depository institution merger applications by Federal depository institution regulatory agencies to ensure they align with statutory requirements (see H.R. 6570), H5559 [10DE]

Government regulations: codify Executive Order 14267 relating to reducing anti-competitive regulatory barriers (see H.R. 4869), H3673 [1AU]

——— repeal legislation that provides price discrimination protection to small businesses (see S. 2099), S3435 [17JN]

Health care facilities: repeal antitrust exemption applicable to graduate medical resident matching programs (see H.R. 3018), H1623 [24AP]

Information technology: promote competition and reduce gatekeeper power in app economy, increase choice and quality, and reduce costs for consumers (see S. 2153), S3516 [24JN]

Mexico: raise concern about constitutional reforms (see H. Res. 454), H2376 [29MY]

Real estate: modify premerger notification requirements relative to certain acquisitions of residential property (see S. 1796), S2952 [15MY]

Small business: permit State attorneys general to bring civil actions for damages as parens patriae for injuries sustained due to price discrimination (see S. 3548), S8832 [17DE] (see H.R. 6830), H6023 [17DE]

Sports: exempt intercollegiate athletic conferences and interstate intercollegiate athletic associations from antitrust laws (see S. 2147), S3516 [24JN]

Motions

Dept. of the Treasury: disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), S2769 [6MY]

Remarks in House

Democratic Party: national agenda, H1260–H1267 [25MR]

Dept. of the Treasury: disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), H2168–H2175 [20MY]

——— disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), consideration (H. Res. 426), H2159–H2168 [20MY]

Remarks in Senate

Dept. of the Treasury: disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), S2764 [6MY], S2789, S2793–S2796 [7MY]

——— disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), motion to proceed, S2769 [6MY]

——— disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications (S.J. Res. 13), unanimous-consent agreement, S2753 [5MY]

Reports filed

Consideration of S.J. Res. 13, Disapprove Office of the Comptroller of the Currency Rule Relative to Review of Bank Merger Applications: Committee on Rules (House) (H. Res. 426) (H. Rept. 119–105), H2145 [19MY]

Drug Competition Enhancement Act: Committee on the Judiciary (Senate) (S. 1040), S2559 [10AP]

Texts of

H. Res. 426, consideration of S.J. Res. 13, disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications, H2159 [20MY]

S.J. Res. 13, disapprove Office of the Comptroller of the Currency rule relative to review of bank merger applications, S2796 [7MY], H2168 [20MY]